Manulife Reports Third Quarter 2026 Results
TSX/NYSE/PSE: MFC SEHK: 945 C$ unless otherwise stated
TORONTO, Nov. 4, 2026 /CNW/ -- Manulife Financial Corporation ("Manulife" or the "Company") reported its third quarter results for the period ended September 30, 2026, delivering record core earnings1 and continued strong momentum in Asia.
Key highlights for the third quarter of 2026 ("3Q26") include:
- Core earnings of $2.1 billion, up 4% on a CER basis2 compared with the third quarter of 2025 ("3Q25")
- Net income attributed to shareholders of $1.4 billion, down $0.4 billion from 3Q25
- Core EPS3 of $1.24, up 6%2 from 3Q25. EPS of $0.82, down 21%2 from 3Q25
- Core ROE3 of 17.8% and ROE of 11.8%
- LICAT ratio4 of 136%
- APE sales5, new business CSM2 and new business value ("NBV")5 were broadly in line with 3Q25
- Global Wealth and Asset Management ("Global WAM") net outflows5 of $3.6 billion, compared with $6.2 billion of net outflows in 3Q25
"We delivered strong third quarter results, achieving record core EPS and 17.8% core ROE, driven by double-digit core earnings growth in Asia and meaningful contributions from our North American insurance businesses. These results reflect the disciplined execution of the strategy we launched a year ago and our ability to deliver sustained growth in an uncertain environment."
"During the quarter, we expanded customer choice through enhanced investment and protection offerings, completed Manulife | Comvest's largest fundraise in the history of Comvest's private credit platform, scaled AI-enabled capabilities that are delivering measurable outcomes for customers and advisors, and advanced new health and longevity solutions and partnerships. Together, these actions are strengthening our competitive position, deepening customer relationships, and creating long-term value for shareholders."
-- Phil Witherington, Manulife President & Chief Executive Officer
"We remained disciplined in our capital deployment during the quarter, returning $1.3 billion to shareholders while maintaining a strong balance sheet, with a LICAT ratio of 136% and a financial leverage ratio3 below our medium-term target. In addition, we completed our annual review of actuarial methods and assumptions, resulting in a net favourable impact and reinforcing the robustness of our reserves."
"As we continue to invest in growth across our businesses, we also further improved our expense efficiency during the quarter. Our financial flexibility and consistent execution position us well to sustain long-term value creation."
-- Colin Simpson, Manulife Chief Financial Officer
Results at a Glance
($ millions, unless otherwise stated) | Quarterly Results | YTD Results | ||||
3Q26 | 3Q25 | Change2,5 | 2026 | 2025 | Change2,5 | |
Net income attributed to shareholders | $ 1,424 | $ 1,799 | (22) % | $ 4,681 | $ 4,073 | 15 % |
Core earnings | $ 2,125 | $ 2,035 | 4 % | $ 5,884 | $ 5,528 | 8 % |
EPS ($) | $ 0.82 | $ 1.02 | (21) % | $ 2.67 | $ 2.25 | 18 % |
Core EPS ($) | $ 1.24 | $ 1.16 | 6 % | $ 3.39 | $ 3.10 | 11 % |
ROE | 11.8 % | 16.0 % | (4.2) pps | 13.3 % | 11.8 % | 1.5 pps |
Core ROE | 17.8 % | 18.1 % | (0.3) pps | 16.9 % | 16.2 % | 0.7 pps |
Book value per common share ($) | $ 28.06 | $ 26.07 | 8 % | $ 28.06 | $ 26.07 | 8 % |
Adjusted book value per common share ($)3 | $ 41.78 | $ 38.22 | 9 % | $ 41.78 | $ 38.22 | 9 % |
Financial leverage ratio (%)3 | 23.0 % | 22.7 % | 0.3 pps | 23.0 % | 22.7 % | 0.3 pps |
APE sales | $ 2,626 | $ 2,576 | (0) % | $ 8,145 | $ 7,495 | 9 % |
New business CSM | $ 957 | $ 966 | (2) % | $ 3,000 | $ 2,755 | 9 % |
NBV | $ 907 | $ 906 | (1) % | $ 2,780 | $ 2,659 | 5 % |
Global WAM net flows ($ billions) | $ (3.6) | $ (6.2) | 43 % | $ (7.5) | $ (4.8) | (60) % |
Results by Segment
($ millions, unless otherwise stated) | Quarterly Results | YTD Results | ||||
3Q26 | 3Q25 | Change5 | 2026 | 2025 | Change5 | |
Asia (US$) | ||||||
Net income attributed to shareholders | $ 510 | $ 649 | (23) % | $ 1,711 | $ 1,684 | 1 % |
Core earnings | 635 | 550 | 17 % | 1,849 | 1,562 | 20 % |
APE sales | 1,455 | 1,452 | (1) % | 4,550 | 4,097 | 10 % |
New business CSM | 518 | 516 | 0 % | 1,664 | 1,494 | 11 % |
NBV | 491 | 490 | 0 % | 1,530 | 1,398 | 9 % |
Canada | ||||||
Net income attributed to shareholders | $ 205 | $ 449 | (54) % | $ 749 | $ 1,061 | (29) % |
Core earnings | 440 | 428 | 3 % | 1,171 | 1,221 | (4) % |
APE sales | 384 | 374 | 3 % | 1,226 | 1,210 | 1 % |
New business CSM | 114 | 109 | 5 % | 346 | 300 | 15 % |
NBV | 159 | 159 | 0 % | 473 | 500 | (5) % |
U.S. (US$) | ||||||
Net income attributed to shareholders | $ 137 | $ (54) | - | $ 348 | $ (425) | - |
Core earnings | 254 | 241 | 5 % | 713 | 633 | 13 % |
APE sales | 147 | 146 | 1 % | 447 | 396 | 13 % |
New business CSM | 85 | 106 | (20) % | 253 | 262 | (3) % |
NBV | 45 | 52 | (13) % | 137 | 146 | (6) % |
Global WAM | ||||||
Net income attributed to shareholders | $ 463 | $ 523 | (13) % | $ 1,380 | $ 1,448 | (4) % |
Core earnings | 503 | 525 | (5) % | 1,456 | 1,442 | 2 % |
Gross flows ($ billions)5 | 56.1 | 47.3 | 16 % | 170.8 | 141.4 | 21 % |
Average AUMA ($ billions)5 | 1,198 | 1,066 | 11 % | 1,158 | 1,038 | 12 % |
Core EBITDA margin (%)3 | 29.6 % | 30.9 % | -130 bps | 30.0 % | 29.8 % | 20 bps |
Strategic Highlights
We are expanding customer access to wealth solutions through product enhancements and expansion
In Canada, we expanded our segregated fund lineup by adding eight new funds and broadened access to eleven existing funds. The enhanced suite increases investment choice and flexibility for customers and advisors, helping Canadians diversify their portfolios, build long-term wealth, and pursue their evolving financial goals.
In Global WAM, we raised US$5.4 billion of capital through the close of Comvest Credit Partners VII. This marked Manulife | Comvest's largest fundraise in the history of Comvest's private credit platform6, attracting commitments from both existing and new institutional investors and expanding the platform's global investor relationships.
In the U.S., we broadened our ability to meet a wider range of customer protection and long-term planning needs through enhancements to our indexed universal life and survivorship indexed universal life solutions, and the introduction of three differentiated term life insurance solutions. Together, these enhancements and new offerings expand our protection portfolio and provide financial professionals with greater choice and flexibility to address evolving customer needs.
We are scaling and advancing solutions as an AI-powered organization while further enhancing AI governance and responsible use
We expanded our strategic partnership with Microsoft through a new five-year agreement. The agreement includes extending Microsoft 365 Copilot to more than 30,000 employees to further enable productivity and innovation, as well as deploying Microsoft Agent 365 to strengthen enterprise AI governance and drive AI solutions at enterprise scale.
In Asia, we continued to extend proven AI-enabled advisory capabilities into new markets, bringing these capabilities to the Chinese Mainland and Malaysia to help agents analyze customer and family coverage, identify protection gaps across life, health, and investment goals, recognize life-event triggers, and prepare for customer meetings. In Malaysia, the tool also generates personalized talking points, including needs-based analysis questions, and recommends next steps linked to customers' financial planning goals.
In Global WAM, we completed the rollout of an AI-enabled advisor engagement platform to all external wholesalers and investment specialists across North America Retail, identifying four times more product opportunities and capturing richer advisor insights. The platform also improved productivity through automated documentation, reducing meeting administration and follow-up activities, saving approximately 30 minutes per session.
In the U.S., we scaled our Quick Quote underwriting support tool to automate more than 70% of preliminary assessments, up from nearly 50% in the first quarter of 2026, rapidly expanding our proven AI-enabled underwriting capability to reduce average turnaround time and optimize our utilization of underwriting expertise.
We are advancing our health and longevity leadership through innovative strategic partnerships, expanded wellness offerings and simpler access to healthcare
In Asia, we signed a Memorandum of Understanding ("MOU") with Ant Health7, setting out a collaboration framework covering health management services, cross-boundary healthcare support, digital health capabilities and insurance technology. In October, we launched the first initiative under the MOU, offering cashless direct billing through Alipay for eligible customers at participating healthcare providers in the Chinese Mainland, making healthcare access easier.
In Canada, we began offering AI-enabled virtual physiotherapy in partnership with Sword®, a global AI health company, to eligible Group Benefits members on disability with musculoskeletal conditions. This initiative helps address barriers to care through convenient, personalized support from licensed Canadian clinicians while supporting faster recovery and return-to-work outcomes.
In the U.S., we strengthened our leadership in longevity and differentiated behavioural insurance by expanding the health and wellness offerings available through John Hancock Vitality, including Prenuvo's advanced heart health scan and ŌURA's latest smart ring, providing customers access to additional tools and insights to help them live longer, healthier, better lives.
Continued business growth drove record core earnings8
Core earnings of $2.1 billion in 3Q26, up 4% from 3Q25
The increase in core earnings reflected strong business growth in Asia and the U.S., higher revenues in Global WAM, improved insurance experience, and the net positive impact of 3Q26 updates to actuarial methods and assumptions, partially offset by increased expected credit loss ("ECL") provisions and the impact of the eMPF transition in Hong Kong.
- Asia core earnings increased 17%, reflecting continued business growth, the net positive impact of 3Q26 updates to actuarial methods and assumptions, improved impact of new business and improved claims experience, partially offset by increased ECL provisions.
- Global WAM core earnings decreased 5%, as higher net fee income from favourable market impacts over the past 12 months and contributions from the Manulife | Comvest business were more than offset by the impact of the eMPF transition in Hong Kong, higher workforce-related expenses and investment in business growth, favourable tax true-ups in 3Q25, and lower performance fees.
- Canada core earnings increased 3%, reflecting more favourable claims experience in Individual Insurance, higher Manulife Bank earnings and higher investment spreads, partially offset by unfavourable claims experience in Group Insurance and increased ECL provisions.
- U.S. core earnings increased 5%, reflecting favourable life insurance claims experience, including net positive impacts from the 3Q26 updates to actuarial methods and assumptions, business growth and favourable tax items, partially offset by increased ECL provisions and unfavourable lapse experience.
- Corporate and Other core earnings decreased by $55 million, driven by the non-recurrence of a 3Q25 withholding tax adjustment and lower earnings on surplus assets, partially offset by favourable tax-related true-ups.
Net income attributed to shareholders of $1.4 billion in 3Q26, $0.4 billion lower compared with 3Q25
The $0.4 billion decrease in net income was driven by a larger net charge on market experience and a net charge from our Vietnam operations9, partially offset by core earnings growth. The net charge from market experience in 3Q26 reflected lower than expected returns on alternative long-duration assets, mainly related to private equity, real estate, and farmland investments, as well as lower than expected returns on public equities and losses from derivatives and hedge accounting ineffectiveness.
Resilient new business results highlight the benefits of our diversified business model
APE sales, new business CSM and NBV were broadly in line with the prior year
- Asia delivered strong sales growth in Hong Kong and Japan, offset by lower sales in the Chinese Mainland. APE sales, new business CSM and NBV were broadly in line with 3Q25. NBV margin was 35.3%.5
- In Canada, APE sales increased 3% and NBV was in line with 3Q25, largely driven by higher Individual Insurance sales, partially offset by lower Group Insurance sales. New business CSM increased 5%, reflecting higher sales volumes in Individual Insurance and higher margins in Annuities, partially offset by lower margins in Individual Insurance.
- U.S. APE sales were in line with 3Q25, while changes in product mix resulted in a decrease in new business CSM and NBV of 20% and 13%, respectively.
Global WAM net outflows of $3.6 billion in 3Q26, compared with net outflows of $6.2 billion in 3Q25
- Retirement net outflows were $4.9 billion in 3Q26 compared with net outflows of $1.6 billion in 3Q25. The variance is attributable to higher retirement plan redemptions in the U.S., higher net member withdrawals reflecting higher account balances from market growth across all regions, and lower new plan sales in Canada.
- Retail net flows were neutral in 3Q26 compared with net outflows of $3.9 billion in 3Q25. The variance is primarily driven by higher net flows through our retail wealth business and third-party intermediaries in Canada, and higher net flows in the Chinese Mainland, partially offset by lower net flows through third-party intermediaries in the U.S.
- Institutional Asset Management net inflows were $1.4 billion in 3Q26 compared with net outflows of $0.7 billion in 3Q25. The variance reflects higher net flows from fixed income mandates, private credit mandates in the Manulife | Comvest business, equity and infrastructure mandates, partially offset by lower net flows from money market mandates in the Chinese Mainland and from Manulife | CQS products.
New business growth continued to drive positive organic CSM movement and a higher CSM balance
CSM10 was $27,318 million as at September 30, 2026
CSM increased $2,349 million compared with December 31, 2025. Organic CSM movement contributed $1,622 million of the increase, representing a 9% annualized growth in our CSM net of NCI balance11, primarily driven by the impact of new business, interest accretion, and net favourable insurance experience, partially offset by amortization recognized in core earnings. Inorganic CSM movement was an increase of $727 million, driven by the favourable impacts of changes in foreign currency exchange rates, partially offset by the net unfavourable impact of markets. Post-tax CSM net of NCI1 was $22,701 million as at September 30, 2026.
Annual review of actuarial methods and assumptions
We completed our annual review of actuarial methods and assumptions, which resulted in a net favourable impact of a $128 million12 decrease in pre-tax fulfilment cash flows. Under International Financial Reporting Standards (as issued by the International Accounting Standards Board) ("IFRS") 17, the impact of the annual review of actuarial methods and assumptions is reported in several places. The $128 million decrease in pre-tax fulfilment cash flows was comprised of a decrease in pre-tax net income attributed to shareholders of $217 million ($175 million post-tax), a decrease in pre-tax net income attributed to participating policyholders of $4 million ($3 million post-tax), an increase in CSM of $47 million, an increase in pre-tax other comprehensive income attributed to shareholders of $306 million ($240 million post-tax), and a decrease in pre-tax other comprehensive income attributed to participating policyholders of $4 million ($2 million post-tax).
The actuarial review this year included valuation model enhancements and assumption updates for U.S. life insurance riders, morbidity and mortality assumptions in Vietnam, valuation model updates for participating products in Asia, lapse assumptions for investment-linked products in Singapore, mortality assumptions in our U.S. life insurance business, and other methodology refinements.
__________________________ | |
(1) | Core earnings and post-tax contractual service margin ("CSM") net of non-controlling interests ("NCI") ("post-tax CSM net of NCI") are non-GAAP financial measures. For more information on non-GAAP and other financial measures, see "Non-GAAP and other financial measures" below and in our 3Q26 Management's Discussion and Analysis ("3Q26 MD&A"). |
(2) | Percentage growth/declines in core earnings, diluted core earnings per common share ("core EPS"), diluted earnings (loss) per share ("EPS"), new business CSM, and net income attributed to shareholders are stated on a constant exchange rate ("CER") basis and are non-GAAP ratios. |
(3) | Core EPS, core return on common shareholders' equity ("ROE"), expense efficiency ratio, adjusted book value per common share, financial leverage ratio, and core earnings before interest, taxes, depreciation and amortization ("EBITDA") margin are non-GAAP ratios. |
(4) | Life Insurance Capital Adequacy Test ("LICAT") ratio of The Manufacturers Life Insurance Company ("MLI") as at September 30, 2026. LICAT ratio is disclosed under the Office of the Superintendent of Financial Institutions LICAT Public Disclosure Requirements guideline. |
(5) | For more information on annualized premium equivalent ("APE") sales, NBV, net flows, gross flows, average assets under management and administration ("average AUMA") and new business value margin ("NBV margin"), see "Non-GAAP and other financial measures" below. In this news release, percentage growth/decline in APE sales, NBV, net flows, gross flows, and average AUMA are stated on a constant exchange rate basis. |
(6) | The largest fundraise in the history of Comvest Credit Partners, including prior to its combination with Manulife. |
(7) | AHA Healthcare Technology HK Limited. |
(8) | See section A1 "Profitability" in our 3Q26 MD&A for more information on notable items attributable to core earnings and net income attributed to shareholders. |
(9) | Reflects a net charge from a partial impairment of a bancassurance asset and a gain on the sale of a Vietnam insurance subsidiary. |
(10) | CSM net of NCI. |
(11) | Percentage growth / decline in our CSM net of NCI balance from organic CSM movement is stated on a constant exchange rate basis and is a non-GAAP ratio. This percentage is calculated as the annualized year-to-date change in organic CSM net of NCI divided by the December 31, 2025 CSM net of NCI balance. |
(12) | This amount excludes the portion related to NCI. |
Earnings Results Conference Call
Manulife will host a conference call and live webcast on its Third Quarter 2026 results on November 5, 2026, at 8:00 a.m. (ET). To access the conference call, dial 1-888-317-6003 or 1-647-846-2809 (Passcode: 0306024#). Please call in 15 minutes before the scheduled start time. You will be required to provide your name and organization to the operator. You may access the webcast at https://www.manulife.com/ca/en/about-us/investors/results-and-reports.
The archived webcast will be available following the call at the same URL as above. A replay of the call will also be available until February 5, 2027, by dialing 1-855-669-9658 or 1-412-317-0088 (Passcode: 8612393#).
The Third Quarter 2026 Statistical Information Package is also available on the Manulife website at https://www.manulife.com/ca/en/about-us/investors/results-and-reports.
This earnings news release should be read in conjunction with the Company's Third Quarter 2026 Report to Shareholders, including our unaudited interim Consolidated Financial Statements for the three and nine months ended September 30, 2026, prepared in accordance with IFRS, which is available on our website at https://www.manulife.com/ca/en/about-us/investors/results-and-reports. The Company's 3Q26 MD&A and additional information relating to the Company is available on the SEDAR+ website at https://www.sedarplus.ca and on the U.S. Securities and Exchange Commission's ("SEC") website at https://www.sec.gov.
Any information contained in, or otherwise accessible through, websites mentioned in this news release does not form a part of this document unless it is expressly incorporated by reference.
Media Inquiries | Investor Relations | |
Fiona McLean | Derek Theobalds | |
(437) 441-7491 | (416) 254-1774 | |
Earnings
The following table presents net income attributed to shareholders, consisting of core earnings and details of the items excluded from core earnings:
Quarterly Results | YTD Results | ||||
($ millions) | 3Q26 | 2Q26 | 3Q25 | 2026 | 2025 |
Core earnings | |||||
Asia | $ 890 | $ 853 | $ 759 | $ 2,563 | $ 2,184 |
Canada | 440 | 379 | 428 | 1,171 | 1,221 |
U.S. | 356 | 301 | 332 | 988 | 887 |
Global Wealth and Asset Management | 503 | 505 | 525 | 1,456 | 1,442 |
Corporate and Other | (64) | (115) | (9) | (294) | (206) |
Total core earnings | $ 2,125 | $ 1,923 | $ 2,035 | $ 5,884 | $ 5,528 |
Items excluded from core earnings | |||||
Market experience gains (losses) | (388) | 201 | (2) | (853) | (1,221) |
Updates to actuarial methods and assumptions that flow directly through income | (175) | - | (216) | (175) | (216) |
Restructuring charge | - | - | - | - | - |
Amortization of acquisition-related intangible assets | (18) | (16) | (6) | (52) | (6) |
Reinsurance transactions, tax-related items and other | (120) | 2 | (12) | (123) | (12) |
Net income attributed to shareholders | $ 1,424 | $ 2,110 | $ 1,799 | $ 4,681 | $ 4,073 |
Non-GAAP and other financial measures
The Company prepares its Consolidated Financial Statements in accordance with IFRS. We use a number of non-GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. This section includes information required by National Instrument 52-112 – Non-GAAP and other Financial Measures Disclosure in respect of "specified financial measures" (as defined therein).
Non-GAAP financial measures include core earnings (loss); core earnings available to common shareholders; core earnings before interest, taxes, depreciation and amortization ("core EBITDA"); core expenses; adjusted book value; post-tax contractual service margin; post-tax contractual service margin net of NCI ("post-tax CSM net of NCI"); and core revenue. In addition, non-GAAP financial measures include the following stated on a constant exchange rate ("CER") basis: any of the foregoing non-GAAP financial measures; net income attributed to shareholders; common shareholders' net income; CSM; CSM net of NCI and new business CSM.
Non-GAAP ratios include core return on common shareholders' equity ("core ROE"); diluted core earnings per common share ("core EPS"); expense efficiency ratio; adjusted book value per common share; financial leverage ratio; core EBITDA margin; growth in the CSM net of NCI from organic CSM movement; and percentage growth/decline on a CER basis in any of the above non-GAAP financial measures and non-GAAP ratios; net income attributed to shareholders; diluted earnings per common share ("EPS"); CSM; CSM net of NCI; and new business CSM.
Other specified financial measures include NBV; APE sales; gross flows; net flows; average assets under management and administration ("average AUMA"); NBV margin; and percentage growth/decline in these foregoing specified financial measures. In addition, explanations of the components of the CSM movement, other than new business CSM are provided in our 3Q26 MD&A.
Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP. For more information on non-GAAP financial measures, including those referred to above, see the section "Non-GAAP and other financial measures" in our 3Q26 MD&A, which is incorporated by reference.
Reconciliation of core earnings to net income attributed to shareholders – 3Q26
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
3Q26 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate and Other | Total | |
Income (loss) before income taxes | $ 857 | $ 265 | $ 217 | $ 565 | $ (151) | $ 1,753 |
Income tax (expenses) recoveries | ||||||
Core earnings | (107) | (114) | (69) | (104) | 61 | (333) |
Items excluded from core earnings | 18 | 71 | 44 | 12 | (56) | 89 |
Income tax (expenses) recoveries | (89) | (43) | (25) | (92) | 5 | (244) |
Net income (post-tax) | 768 | 222 | 192 | 473 | (146) | 1,509 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 8 | - | - | 10 | 3 | 21 |
Participating policyholders | 47 | 17 | - | - | - | 64 |
Net income (loss) attributed to shareholders (post-tax) | 713 | 205 | 192 | 463 | (149) | 1,424 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | (87) | (143) | (71) | (25) | (62) | (388) |
Updates to actuarial methods and assumptions that flow directly through income | 10 | (92) | (93) | - | - | (175) |
Restructuring charge | - | - | - | - | - | - |
Amortization of acquisition-related intangible assets | - | - | - | (18) | - | (18) |
Reinsurance transactions, tax-related items and other | (100) | - | - | 3 | (23) | (120) |
Core earnings (post-tax) | $ 890 | $ 440 | $ 356 | $ 503 | $ (64) | $ 2,125 |
Income tax on core earnings (see above) | 107 | 114 | 69 | 104 | (61) | 333 |
Core earnings (pre-tax) | $ 997 | $ 554 | $ 425 | $ 607 | $ (125) | $ 2,458 |
Core earnings, CER basis and U.S. dollars – 3Q26
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
3Q26 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate and Other | Total | |
Core earnings (post-tax) | $ 890 | $ 440 | $ 356 | $ 503 | $ (64) | $ 2,125 |
CER adjustment(1) | - | - | - | - | - | - |
Core earnings, CER basis (post-tax) | $ 890 | $ 440 | $ 356 | $ 503 | $ (64) | $ 2,125 |
Income tax on core earnings, CER basis(2) | 107 | 114 | 69 | 104 | (61) | 333 |
Core earnings, CER basis (pre-tax) | $ 997 | $ 554 | $ 425 | $ 607 | $ (125) | $ 2,458 |
Core earnings (U.S. dollars) – Asia and U.S. segments | ||||||
Core earnings (post-tax)(3), US $ | $ 635 | $ 254 | ||||
CER adjustment US $(1) | - | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 635 | $ 254 | ||||
(1) The impact of updating foreign exchange rates to that which was used in 3Q26. |
Reconciliation of core earnings to net income attributed to shareholders – 2Q26
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
2Q26 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate and Other | Total | |
Income (loss) before income taxes | $ 1,464 | $ 401 | $ 181 | $ 623 | $ 103 | $ 2,772 |
Income tax (expenses) recoveries | ||||||
Core earnings | (123) | (97) | (67) | (101) | 31 | (357) |
Items excluded from core earnings | (107) | 27 | 39 | (2) | (54) | (97) |
Income tax (expenses) recoveries | (230) | (70) | (28) | (103) | (23) | (454) |
Net income (post-tax) | 1,234 | 331 | 153 | 520 | 80 | 2,318 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 126 | - | - | 6 | 5 | 137 |
Participating policyholders | 46 | 25 | - | - | - | 71 |
Net income (loss) attributed to shareholders (post-tax) | 1,062 | 306 | 153 | 514 | 75 | 2,110 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | 209 | (70) | (150) | 22 | 190 | 201 |
Updates to actuarial methods and assumptions that flow directly through income | - | - | - | - | - | - |
Restructuring charge | - | - | - | - | - | - |
Amortization of acquisition-related intangible assets | - | - | - | (16) | - | (16) |
Reinsurance transactions, tax-related items and other | - | (3) | 2 | 3 | - | 2 |
Core earnings (post-tax) | $ 853 | $ 379 | $ 301 | $ 505 | $ (115) | $ 1,923 |
Income tax on core earnings (see above) | 123 | 97 | 67 | 101 | (31) | 357 |
Core earnings (pre-tax) | $ 976 | $ 476 | $ 368 | $ 606 | $ (146) | $ 2,280 |
Core earnings, CER basis and U.S. dollars – 2Q26
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
2Q26 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate | Total | |
Core earnings (post-tax) | $ 853 | $ 379 | $ 301 | $ 505 | $ (115) | $ 1,923 |
CER adjustment(1) | 9 | - | 4 | 4 | - | 17 |
Core earnings, CER basis (post-tax) | $ 862 | $ 379 | $ 305 | $ 509 | $ (115) | $ 1,940 |
Income tax on core earnings, CER basis(2) | 125 | 97 | 67 | 102 | (31) | 360 |
Core earnings, CER basis (pre-tax) | $ 987 | $ 476 | $ 372 | $ 611 | $ (146) | $ 2,300 |
Core earnings (U.S. dollars) – Asia and U.S. segments | ||||||
Core earnings (post-tax)(3), US $ | $ 616 | $ 218 | ||||
CER adjustment US $(1) | (1) | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 615 | $ 218 | ||||
(1) | The impact of updating foreign exchange rates to that which was used in 3Q26. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q26. |
(3) | Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for 2Q26. |
Reconciliation of core earnings to net income attributed to shareholders – 3Q25
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
3Q25 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate | Total | |
Income (loss) before income taxes | $ 1,268 | $ 551 | $ (109) | $ 606 | $ (87) | $ 2,229 |
Income tax (expenses) recoveries | ||||||
Core earnings | (93) | (119) | (79) | (82) | 91 | (282) |
Items excluded from core earnings | (140) | (5) | 113 | 1 | 3 | (28) |
Income tax (expenses) recoveries | (233) | (124) | 34 | (81) | 94 | (310) |
Net income (post-tax) | 1,035 | 427 | (75) | 525 | 7 | 1,919 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 128 | - | - | 2 | - | 130 |
Participating policyholders | 12 | (22) | - | - | - | (10) |
Net income (loss) attributed to shareholders (post-tax) | 895 | 449 | (75) | 523 | 7 | 1,799 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | 173 | (37) | (172) | 18 | 16 | (2) |
Updates to actuarial methods and assumptions that flow directly through income | (39) | 58 | (235) | - | - | (216) |
Restructuring charge | - | - | - | - | - | - |
Amortization of acquisition-related intangible assets | - | - | - | (6) | - | (6) |
Reinsurance transactions, tax-related items and other | 2 | - | - | (14) | - | (12) |
Core earnings (post-tax) | $ 759 | $ 428 | $ 332 | $ 525 | $ (9) | $ 2,035 |
Income tax on core earnings (see above) | 93 | 119 | 79 | 82 | (91) | 282 |
Core earnings (pre-tax) | $ 852 | $ 547 | $ 411 | $ 607 | $ (100) | $ 2,317 |
Core earnings, CER basis and U.S. dollars – 3Q25
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
3Q25 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate | Total | |
Core earnings (post-tax) | $ 759 | $ 428 | $ 332 | $ 525 | $ (9) | $ 2,035 |
CER adjustment(1) | 1 | - | 6 | 4 | 1 | 12 |
Core earnings, CER basis (post-tax) | $ 760 | $ 428 | $ 338 | $ 529 | $ (8) | $ 2,047 |
Income tax on core earnings, CER basis(2) | 94 | 119 | 80 | 82 | (90) | 285 |
Core earnings, CER basis (pre-tax) | $ 854 | $ 547 | $ 418 | $ 611 | $ (98) | $ 2,332 |
Core earnings (U.S. dollars) – Asia and U.S. segments | ||||||
Core earnings (post-tax)(3), US $ | $ 550 | $ 241 | ||||
CER adjustment US $(1) | (8) | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 542 | $ 241 | ||||
(1) | The impact of updating foreign exchange rates to that which was used in 3Q26. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q26. |
(3) | Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for 3Q25. |
Reconciliation of core earnings to net income attributed to shareholders – YTD 2026
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2026 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate and Other | Total | |
Income (loss) before income taxes | $ 3,097 | $ 991 | $ 557 | $ 1,677 | $ (331) | $ 5,991 |
Income tax (expenses) recoveries | ||||||
Core earnings | (330) | (299) | (214) | (293) | 134 | (1,002) |
Items excluded from core earnings | (116) | 124 | 140 | 22 | (96) | 74 |
Income tax (expenses) recoveries | (446) | (175) | (74) | (271) | 38 | (928) |
Net income (post-tax) | 2,651 | 816 | 483 | 1,406 | (293) | 5,063 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 167 | - | - | 26 | 8 | 201 |
Participating policyholders | 114 | 67 | - | - | - | 181 |
Net income (loss) attributed to shareholders (post-tax) | 2,370 | 749 | 483 | 1,380 | (301) | 4,681 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | (103) | (327) | (414) | (25) | 16 | (853) |
Updates to actuarial methods and assumptions that flow directly through income | 10 | (92) | (93) | - | - | (175) |
Restructuring charge | - | - | - | - | - | - |
Amortization of acquisition-related intangible assets | - | - | - | (52) | - | (52) |
Reinsurance transactions, tax-related items and other | (100) | (3) | 2 | 1 | (23) | (123) |
Core earnings (post-tax) | $ 2,563 | $ 1,171 | $ 988 | $ 1,456 | $ (294) | $ 5,884 |
Income tax on core earnings (see above) | 330 | 299 | 214 | 293 | (134) | 1,002 |
Core earnings (pre-tax) | $ 2,893 | $ 1,470 | $ 1,202 | $ 1,749 | $ (428) | $ 6,886 |
Core earnings, CER basis and U.S. dollars – YTD 2026
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2026 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate and Other | Total | |
Core earnings (post-tax) | $ 2,563 | $ 1,171 | $ 988 | $ 1,456 | $ (294) | $ 5,884 |
CER adjustment(1) | 23 | - | 10 | 10 | 1 | 44 |
Core earnings, CER basis (post-tax) | $ 2,586 | $ 1,171 | $ 998 | $ 1,466 | $ (293) | $ 5,928 |
Income tax on core earnings, CER basis(2) | 333 | 299 | 217 | 295 | (135) | 1,009 |
Core earnings, CER basis (pre-tax) | $ 2,919 | $ 1,470 | $ 1,215 | $ 1,761 | $ (428) | $ 6,937 |
Core earnings (U.S. dollars) – Asia and U.S. segments | ||||||
Core earnings (post-tax)(3), US $ | $ 1,849 | $ 713 | ||||
CER adjustment US $(1) | (3) | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 1,846 | $ 713 | ||||
(1) | The impact of updating foreign exchange rates to that which was used in 3Q26. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q26. |
(3) | Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for the respective quarters that make up 2026 year-to-date core earnings. |
Reconciliation of core earnings to net income attributed to shareholders – YTD 2025
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2025 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate and Other | Total | |
Income (loss) before income taxes | $ 3,230 | $ 1,382 | $ (809) | $ 1,709 | $ (323) | $ 5,189 |
Income tax (expenses) recoveries | ||||||
Core earnings | (288) | (318) | (200) | (257) | 152 | (911) |
Items excluded from core earnings | (225) | 20 | 401 | (1) | (8) | 187 |
Income tax (expenses) recoveries | (513) | (298) | 201 | (258) | 144 | (724) |
Net income (post-tax) | 2,717 | 1,084 | (608) | 1,451 | (179) | 4,465 |
Less: Net income (post-tax) attributed to | ||||||
Non-controlling interests | 244 | - | - | 3 | (2) | 245 |
Participating policyholders | 124 | 23 | - | - | - | 147 |
Net income (loss) attributed to shareholders (post-tax) | 2,349 | 1,061 | (608) | 1,448 | (177) | 4,073 |
Less: Items excluded from core earnings (post-tax) | ||||||
Market experience gains (losses) | 257 | (216) | (1,260) | 23 | (25) | (1,221) |
Updates to actuarial methods and assumptions that flow directly through income | (39) | 58 | (235) | - | - | (216) |
Restructuring charge | - | - | - | - | - | - |
Amortization of acquisition-related intangible assets | - | - | - | (6) | - | (6) |
Reinsurance transactions, tax-related items and other | (53) | (2) | - | (11) | 54 | (12) |
Core earnings (post-tax) | $ 2,184 | $ 1,221 | $ 887 | $ 1,442 | $ (206) | $ 5,528 |
Income tax on core earnings (see above) | 288 | 318 | 200 | 257 | (152) | 911 |
Core earnings (pre-tax) | $ 2,472 | $ 1,539 | $ 1,087 | $ 1,699 | $ (358) | $ 6,439 |
Core earnings, CER basis and U.S. dollars – YTD 2025
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
YTD 2025 | ||||||
Asia | Canada | U.S. | Global WAM | Corporate and Other | Total | |
Core earnings (post-tax) | $ 2,184 | $ 1,221 | $ 887 | $ 1,442 | $ (206) | $ 5,528 |
CER adjustment(1) | (24) | - | - | (2) | 1 | (25) |
Core earnings, CER basis (post-tax) | $ 2,160 | $ 1,221 | $ 887 | $ 1,440 | $ (205) | $ 5,503 |
Income tax on core earnings, CER basis(2) | 286 | 318 | 199 | 256 | (151) | 908 |
Core earnings, CER basis (pre-tax) | $ 2,446 | $ 1,539 | $ 1,086 | $ 1,696 | $ (356) | $ 6,411 |
Core earnings (U.S. dollars) – Asia and U.S. segments | ||||||
Core earnings (post-tax)(3), US $ | $ 1,562 | $ 633 | ||||
CER adjustment US $(1) | (20) | - | ||||
Core earnings, CER basis (post-tax), US $ | $ 1,542 | $ 633 | ||||
(1) | The impact of updating foreign exchange rates to that which was used in 3Q26. |
(2) | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q26. |
(3) | Core earnings (post-tax) in Canadian $ are translated to US $ using the US $ Statement of Income exchange rate for the respective quarters that make up 2025 year-to-date core earnings. |
Core earnings available to common shareholders
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q26 | 2Q26 | 1Q26 | 4Q25 | 3Q25 | 2026 | 2025 | 2025 | |
Core earnings | $ 2,125 | $ 1,923 | $ 1,836 | $ 1,993 | $ 2,035 | $ 5,884 | $ 5,528 | $ 7,521 |
Less: Preferred share dividends and other equity distributions | 59 | 103 | 58 | 103 | 58 | 220 | 218 | 321 |
Core earnings available to common shareholders | 2,066 | 1,820 | 1,778 | 1,890 | 1,977 | 5,664 | 5,310 | 7,200 |
CER adjustment(1) | - | 17 | 27 | 2 | 12 | 44 | (25) | (23) |
Core earnings available to common shareholders, CER basis | $ 2,066 | $ 1,837 | $ 1,805 | $ 1,892 | $ 1,989 | $ 5,708 | $ 5,285 | $ 7,177 |
(1) The impact of updating foreign exchange rates to that which was used in 3Q26. |
Core ROE
($ millions, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q26 | 2Q26 | 1Q26 | 4Q25 | 3Q25 | 2026 | 2025 | 2025 | |
Core earnings available to common shareholders | $ 2,066 | $ 1,820 | $ 1,778 | $ 1,890 | $ 1,977 | $ 5,664 | $ 5,310 | $ 7,200 |
Annualized core earnings available to common shareholders (post-tax) | $ 8,197 | $ 7,300 | $ 7,211 | $ 7,498 | $ 7,844 | $ 7,573 | $ 7,099 | $ 7,200 |
Average common shareholders' equity (see below) | $ 46,038 | $ 44,818 | $ 43,717 | $ 43,759 | $ 43,238 | $ 44,858 | $ 43,693 | $ 43,709 |
Core ROE (annualized) (%) | 17.8 % | 16.3 % | 16.5 % | 17.1 % | 18.1 % | 16.9 % | 16.2 % | 16.5 % |
Average common shareholders' equity | ||||||||
Total shareholders' and other equity | $ 53,072 | $ 52,324 | $ 50,632 | $ 50,121 | $ 50,716 | $ 53,072 | $ 50,716 | $ 50,121 |
Less: Preferred shares and other equity | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 |
Common shareholders' equity | $ 46,412 | $ 45,664 | $ 43,972 | $ 43,461 | $ 44,056 | $ 46,412 | $ 44,056 | $ 43,461 |
Average common shareholders' equity | $ 46,038 | $ 44,818 | $ 43,717 | $ 43,759 | $ 43,238 | $ 44,858 | $ 43,693 | $ 43,709 |
CSM and post-tax CSM information
($ millions pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
As at | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 |
CSM | $ 29,070 | $ 29,205 | $ 27,325 | $ 26,568 | $ 26,283 |
Less: CSM for NCI | 1,752 | 1,942 | 1,736 | 1,599 | 1,565 |
CSM, net of NCI | $ 27,318 | $ 27,263 | $ 25,589 | $ 24,969 | $ 24,718 |
CER adjustment(1) | - | 175 | 472 | 795 | 379 |
CSM, net of NCI, CER basis | $ 27,318 | $ 27,438 | $ 26,061 | $ 25,764 | $ 25,097 |
CSM by segment | |||||
Asia | $ 19,741 | $ 19,562 | $ 18,228 | $ 17,750 | $ 17,580 |
Asia NCI | 1,752 | 1,942 | 1,736 | 1,599 | 1,565 |
Canada | 4,351 | 4,509 | 4,432 | 4,459 | 4,490 |
U.S. | 3,220 | 3,188 | 2,927 | 2,760 | 2,649 |
Corporate and Other | 6 | 4 | 2 | - | (1) |
CSM | $ 29,070 | $ 29,205 | $ 27,325 | $ 26,568 | $ 26,283 |
CSM, CER adjustment(1) | |||||
Asia | $ - | $ 173 | $ 422 | $ 696 | $ 326 |
Asia NCI | - | 22 | 79 | 120 | 123 |
Canada | - | - | - | - | - |
U.S. | - | 3 | 51 | 99 | 54 |
Corporate and Other | - | (1) | - | - | - |
Total | $ - | $ 197 | $ 552 | $ 915 | $ 503 |
CSM, CER basis | |||||
Asia | $ 19,741 | $ 19,735 | $ 18,650 | $ 18,446 | $ 17,906 |
Asia NCI | 1,752 | 1,964 | 1,815 | 1,719 | 1,688 |
Canada | 4,351 | 4,509 | 4,432 | 4,459 | 4,490 |
U.S. | 3,220 | 3,191 | 2,978 | 2,859 | 2,703 |
Corporate and Other | 6 | 3 | 2 | - | (1) |
Total CSM, CER basis | $ 29,070 | $ 29,402 | $ 27,877 | $ 27,483 | $ 26,786 |
Post-tax CSM | |||||
CSM | $ 29,070 | $ 29,205 | $ 27,325 | $ 26,568 | $ 26,283 |
Marginal tax rate on CSM | (4,802) | (4,781) | (4,510) | (4,403) | (4,347) |
Post-tax CSM | $ 24,268 | $ 24,424 | $ 22,815 | $ 22,165 | $ 21,936 |
CSM, net of NCI | $ 27,318 | $ 27,263 | $ 25,589 | $ 24,969 | $ 24,718 |
Marginal tax rate on CSM net of NCI | (4,617) | (4,596) | (4,334) | (4,236) | (4,181) |
Post-tax CSM net of NCI | $ 22,701 | $ 22,667 | $ 21,255 | $ 20,733 | $ 20,537 |
(1) The impact of reflecting CSM and CSM net of NCI using the foreign exchange rates for the Statement of Financial Position in effect for 3Q26. |
New business CSM(1) detail, CER basis
($ millions pre-tax, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q26 | 2Q26 | 1Q26 | 4Q25 | 3Q25 | 2026 | 2025 | 2025 | |
New business CSM | ||||||||
Hong Kong | $ 385 | $ 322 | $ 316 | $ 244 | $ 287 | $ 1,023 | $ 889 | $ 1,133 |
Japan | 104 | 122 | 167 | 159 | 76 | 393 | 231 | 390 |
Chinese Mainland | 43 | 66 | 114 | 55 | 112 | 223 | 301 | 356 |
Singapore | 155 | 228 | 165 | 159 | 182 | 548 | 460 | 619 |
Other(2) | 38 | 39 | 40 | 80 | 55 | 117 | 209 | 289 |
Asia | 725 | 777 | 802 | 697 | 712 | 2,304 | 2,090 | 2,787 |
Canada | 114 | 129 | 103 | 135 | 109 | 346 | 300 | 435 |
U.S. | 118 | 118 | 114 | 188 | 145 | 350 | 365 | 553 |
Total new business CSM | $ 957 | $ 1,024 | $ 1,019 | $ 1,020 | $ 966 | $ 3,000 | $ 2,755 | $ 3,775 |
New business CSM, CER adjustment(3) | ||||||||
Hong Kong | $ - | $ 3 | $ 6 | $ 1 | $ 5 | $ 9 | $ 1 | $ 2 |
Japan | - | 1 | 1 | (4) | (5) | 2 | (16) | (21) |
Chinese Mainland | - | 1 | 6 | 3 | 9 | 7 | 20 | 23 |
Singapore | - | 2 | 3 | 2 | 4 | 5 | 11 | 13 |
Other(2) | - | 1 | - | (1) | (1) | 1 | (2) | (2) |
Asia | - | 8 | 16 | 1 | 12 | 24 | 14 | 15 |
Canada | - | - | - | - | - | - | - | - |
U.S. | - | - | 3 | - | 3 | 3 | 1 | 1 |
Total new business CSM | $ - | $ 8 | $ 19 | $ 1 | $ 15 | $ 27 | $ 15 | $ 16 |
New business CSM, CER basis | ||||||||
Hong Kong | $ 385 | $ 325 | $ 322 | $ 245 | $ 292 | $ 1,032 | $ 890 | $ 1,135 |
Japan | 104 | 123 | 168 | 155 | 71 | 395 | 215 | 369 |
Chinese Mainland | 43 | 67 | 120 | 58 | 121 | 230 | 321 | 379 |
Singapore | 155 | 230 | 168 | 161 | 186 | 553 | 471 | 632 |
Other(2) | 38 | 40 | 40 | 79 | 54 | 118 | 207 | 287 |
Asia | 725 | 785 | 818 | 698 | 724 | 2,328 | 2,104 | 2,802 |
Canada | 114 | 129 | 103 | 135 | 109 | 346 | 300 | 435 |
U.S. | 118 | 118 | 117 | 188 | 148 | 353 | 366 | 554 |
Total new business CSM, CER basis | $ 957 | $ 1,032 | $ 1,038 | $ 1,021 | $ 981 | $ 3,027 | $ 2,770 | $ 3,791 |
(1) New business CSM is net of NCI. |
(2) Other includes Cambodia, Indonesia, International High Net Worth, Malaysia, Myanmar, the Philippines and Vietnam. |
(3) The impact of updating foreign exchange rates to that which was used in 3Q26. |
Net income financial measures on a CER basis
($ Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q26 | 2Q26 | 1Q26 | 4Q25 | 3Q25 | 2026 | 2025 | 2025 | |
Net income (loss) attributed to shareholders: | ||||||||
Asia | $ 713 | $ 1,062 | $ 595 | $ 623 | $ 895 | $ 2,370 | $ 2,349 | $ 2,972 |
Canada | 205 | 306 | 238 | 252 | 449 | 749 | 1,061 | 1,313 |
U.S. | 192 | 153 | 138 | 81 | (75) | 483 | (608) | (527) |
Global WAM | 463 | 514 | 403 | 452 | 523 | 1,380 | 1,448 | 1,900 |
Corporate and Other | (149) | 75 | (227) | 91 | 7 | (301) | (177) | (86) |
Total net income (loss) attributed to shareholders | 1,424 | 2,110 | 1,147 | 1,499 | 1,799 | 4,681 | 4,073 | 5,572 |
Preferred share dividends and other equity distributions | (59) | (103) | (58) | (103) | (58) | (220) | (218) | (321) |
Common shareholders' net income (loss) | $ 1,365 | $ 2,007 | $ 1,089 | $ 1,396 | $ 1,741 | $ 4,461 | $ 3,855 | $ 5,251 |
CER adjustment(1) | ||||||||
Asia | $ - | $ 12 | $ 10 | $ 2 | $ 32 | $ 22 | $ 21 | $ 24 |
Canada | - | - | - | - | - | - | - | - |
U.S. | - | 2 | 3 | - | (3) | 5 | 12 | 12 |
Global WAM | - | 5 | 7 | - | 7 | 12 | (3) | (3) |
Corporate and Other | - | 4 | (5) | (1) | 1 | (1) | 16 | 14 |
Total net income (loss) attributed to shareholders | - | 23 | 15 | 1 | 37 | 38 | 46 | 47 |
Preferred share dividends and other equity distributions | - | - | - | - | - | - | - | - |
Common shareholders' net income (loss) | $ - | $ 23 | $ 15 | $ 1 | $ 37 | $ 38 | $ 46 | $ 47 |
Net income (loss) attributed to shareholders, CER basis | ||||||||
Asia | $ 713 | $ 1,074 | $ 605 | $ 625 | $ 927 | $ 2,392 | $ 2,370 | $ 2,996 |
Canada | 205 | 306 | 238 | 252 | 449 | 749 | 1,061 | 1,313 |
U.S. | 192 | 155 | 141 | 81 | (78) | 488 | (596) | (515) |
Global WAM | 463 | 519 | 410 | 452 | 530 | 1,392 | 1,445 | 1,897 |
Corporate and Other | (149) | 79 | (232) | 90 | 8 | (302) | (161) | (72) |
Total net income (loss) attributed to shareholders, CER basis | 1,424 | 2,133 | 1,162 | 1,500 | 1,836 | 4,719 | 4,119 | 5,619 |
Preferred share dividends and other equity distributions, CER basis | (59) | (103) | (58) | (103) | (58) | (220) | (218) | (321) |
Common shareholders' net income (loss), CER basis | $ 1,365 | $ 2,030 | $ 1,104 | $ 1,397 | $ 1,778 | $ 4,499 | $ 3,901 | $ 5,298 |
Asia net income attributed to shareholders, U.S. dollars | ||||||||
Asia net income (loss) attributed to shareholders, US $(2) | $ 510 | $ 768 | $ 433 | $ 447 | $ 649 | $ 1,711 | $ 1,684 | $ 2,131 |
CER adjustment, US $(1) | - | (1) | (1) | (1) | 14 | (2) | 9 | 8 |
Asia net income (loss) attributed to shareholders, U.S. $, CER basis(1) | $ 510 | $ 767 | $ 432 | $ 446 | $ 663 | $ 1,709 | $ 1,693 | $ 2,139 |
Net income (loss) attributed to shareholders (pre-tax) | ||||||||
Net income (loss) attributed to shareholders (post-tax) | $ 1,424 | $ 2,110 | $ 1,147 | $ 1,499 | $ 1,799 | $ 4,681 | $ 4,073 | $ 5,572 |
Tax on net income attributed to shareholders | 254 | 427 | 215 | 292 | 283 | 896 | 637 | 929 |
Net income (loss) attributed to shareholders (pre-tax) | 1,678 | 2,537 | 1,362 | 1,791 | 2,082 | 5,577 | 4,710 | 6,501 |
CER adjustment(1) | - | 23 | 19 | 6 | 7 | 42 | (3) | 3 |
Net income (loss) attributed to shareholders (pre-tax), CER basis | $ 1,678 | $ 2,560 | $ 1,381 | $ 1,797 | $ 2,089 | $ 5,619 | $ 4,707 | $ 6,504 |
(1) | The impact of updating foreign exchange rates to that which was used in 3Q26. |
(2) | Asia net income attributed to shareholders (post-tax) in Canadian dollars is translated to U.S. dollars using the U.S. dollar Statement of Income rate for the respective reporting period. |
Adjusted book value
($ millions)
Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | |
As at | |||||
Common shareholders' equity | $ 46,412 | $ 45,664 | $ 43,972 | $ 43,461 | $ 44,056 |
Post-tax CSM, net of NCI | 22,701 | 22,667 | 21,255 | 20,733 | 20,537 |
Adjusted book value | $ 69,113 | $ 68,331 | $ 65,227 | $ 64,194 | $ 64,593 |
Reconciliation of Global WAM core earnings to core EBITDA
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q26 | 2Q26 | 1Q26 | 4Q25 | 3Q25 | 2026 | 2025 | 2025 | |
Global WAM core earnings (post-tax) | $ 503 | $ 505 | $ 448 | $ 490 | $ 525 | $ 1,456 | $ 1,442 | $ 1,932 |
Add back taxes, acquisition costs, other expenses and deferred sales commissions | ||||||||
Core income tax (expenses) recoveries (see above) | 104 | 101 | 88 | 93 | 82 | 293 | 257 | 350 |
Amortization of deferred acquisition costs and other depreciation | 43 | 62 | 63 | 61 | 44 | 168 | 141 | 202 |
Amortization of deferred sales commissions | 27 | 25 | 24 | 24 | 21 | 76 | 63 | 87 |
Core EBITDA | $ 677 | $ 693 | $ 623 | $ 668 | $ 672 | $ 1,993 | $ 1,903 | $ 2,571 |
CER adjustment(1) | - | 6 | 8 | 1 | 7 | 14 | (2) | (1) |
Core EBITDA, CER basis | $ 677 | $ 699 | $ 631 | $ 669 | $ 679 | $ 2,007 | $ 1,901 | $ 2,570 |
(1) The impact of updating foreign exchange rates to that which was used in 3Q26. |
Core EBITDA margin and core revenue
($ millions, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q26 | 2Q26 | 1Q26 | 4Q25 | 3Q25 | 2026 | 2025 | 2025 | |
Core EBITDA margin | ||||||||
Core EBITDA | $ 677 | $ 693 | $ 623 | $ 668 | $ 672 | $ 1,993 | $ 1,903 | $ 2,571 |
Core revenue | $ 2,288 | $ 2,220 | $ 2,146 | $ 2,285 | $ 2,175 | $ 6,654 | $ 6,384 | $ 8,669 |
Core EBITDA margin | 29.6 % | 31.2 % | 29.0 % | 29.2 % | 30.9 % | 30.0 % | 29.8 % | 29.7 % |
Global WAM core revenue | ||||||||
Other revenue per financial statements | $ 2,077 | $ 2,216 | $ 1,930 | $ 2,147 | $ 2,145 | $ 6,223 | $ 5,982 | $ 8,129 |
Less: Other revenue in segments other than Global WAM | (74) | 155 | (56) | 28 | 121 | 25 | 79 | 107 |
Other revenue in Global WAM (fee income) | $ 2,151 | $ 2,061 | $ 1,986 | $ 2,119 | $ 2,024 | $ 6,198 | $ 5,903 | $ 8,022 |
Investment income per financial statements | $ 5,087 | $ 4,875 | $ 4,536 | $ 5,358 | $ 4,682 | $ 14,498 | $ 13,656 | $ 19,014 |
Realized and unrealized gains (losses) on assets supporting insurance and investment contract liabilities per financial statements | (2,237) | 5,705 | (1,384) | 1,106 | 3,784 | 2,084 | 5,169 | 6,275 |
Total investment income | 2,850 | 10,580 | 3,152 | 6,464 | 8,466 | 16,582 | 18,825 | 25,289 |
Less: Investment income in segments other than Global WAM | 2,727 | 10,370 | 3,015 | 6,300 | 8,275 | 16,112 | 18,288 | 24,588 |
Investment income in Global WAM | $ 123 | $ 210 | $ 137 | $ 164 | $ 191 | $ 470 | $ 537 | $ 701 |
Total other revenue and investment income in Global WAM | $ 2,274 | $ 2,271 | $ 2,123 | $ 2,283 | $ 2,215 | $ 6,668 | $ 6,440 | $ 8,723 |
Less: Total revenue reported in items excluded from core earnings | ||||||||
Market experience gains (losses) | (33) | 28 | (28) | (1) | 24 | (33) | 30 | 29 |
Revenue related to integration and acquisitions | 19 | 23 | 5 | (1) | 16 | 47 | 26 | 25 |
Global WAM core revenue | $ 2,288 | $ 2,220 | $ 2,146 | $ 2,285 | $ 2,175 | $ 6,654 | $ 6,384 | $ 8,669 |
Core expenses
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Quarterly Results | YTD Results | Full Year | ||||||
3Q26 | 2Q26 | 1Q26 | 4Q25 | 3Q25 | 2026 | 2025 | 2025 | |
Core expenses | ||||||||
General expenses – Statements of Income | $ 1,259 | $ 1,248 | $ 1,251 | $ 1,327 | $ 1,232 | $ 3,758 | $ 3,574 | $ 4,901 |
Directly attributable acquisition expense for contracts measured using the PAA method and products without a CSM(1) | 45 | 43 | 48 | 48 | 42 | 136 | 124 | 172 |
Directly attributable maintenance expense(1) | 557 | 559 | 552 | 542 | 524 | 1,668 | 1,570 | 2,112 |
Total expenses | 1,861 | 1,850 | 1,851 | 1,917 | 1,798 | 5,562 | 5,268 | 7,185 |
Less: General expenses included in items excluded from core earnings | ||||||||
Restructuring charge | - | - | - | 16 | - | - | - | 16 |
Amortization of acquisition-related intangible assets | 24 | 21 | 23 | 16 | 8 | 68 | 8 | 24 |
Integration and acquisition | - | - | - | 7 | 22 | - | 22 | 29 |
Legal provisions and other expenses | 4 | 3 | 1 | 5 | 10 | 8 | 15 | 20 |
Total | 28 | 24 | 24 | 44 | 40 | 76 | 45 | 89 |
Core expenses | $ 1,833 | $ 1,826 | $ 1,827 | $ 1,873 | $ 1,758 | $ 5,486 | $ 5,223 | $ 7,096 |
CER adjustment(2) | - | 10 | 19 | 2 | 12 | 29 | (3) | (1) |
Core expenses, CER basis | $ 1,833 | $ 1,836 | $ 1,846 | $ 1,875 | $ 1,770 | $ 5,515 | $ 5,220 | $ 7,095 |
Total expenses | $ 1,861 | $ 1,850 | $ 1,851 | $ 1,917 | $ 1,798 | $ 5,562 | $ 5,268 | $ 7,185 |
CER adjustment(2) | - | 10 | 19 | 2 | 13 | 29 | (2) | 1 |
Total expenses, CER basis | $ 1,861 | $ 1,860 | $ 1,870 | $ 1,919 | $ 1,811 | $ 5,591 | $ 5,266 | $ 7,186 |
(1) | Expenses are components of insurance service expenses on the Statements of Income that flow directly through income. |
(2) | The impact of updating foreign exchange rates to that which was used in 3Q26. |
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
From time to time, Manulife makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995.
The forward-looking statements in this document include, but are not limited to, statements with respect to our ability to achieve our medium-term financial and operating targets, and the expected benefits and value derived from the use of AI and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "suspect", "outlook", "expect", "intend", "estimate", "anticipate", "believe", "plan", "forecast", "objective", "seek", "aim", "continue", "goal", "restore", "embark" and "endeavour" (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts' expectations in any way.
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.
Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to obtain premium rate increases on in-force policies; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies and actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified fair value through other comprehensive income; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our operations; geopolitical uncertainty, including international conflicts and trade disputes; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company's or public infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property and exposure to claims of infringement; our ability to execute our digital plans and to deploy future digital use cases, including with respect to AI, and our inability to withdraw cash from subsidiaries.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found under "Risk Management and Risk Factors" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent annual report, under "Risk Management and Risk Factors Update" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and Analysis in our most recent interim report, and in the "Risk Management" note to the Consolidated Financial Statements in our most recent annual and interim reports, as well as elsewhere in our filings with Canadian and U.S. securities regulators.
The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.
SOURCE Manulife Financial Corporation
Share this article